Fig. 2From: Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis: systematic review and network meta-analysis of trials including recommended dosagesPairwise meta-analyses for annualised relapse rate. IFN: interferon, GA: glatiramer acetate, IM: intramuscular, SC: subcutaneousBack to article page